ARCHIVES

B-14 Trial: No Advantage To 10 Years Of Tamoxifen

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Researchers Link Obesity With 34% Higher Death Risk In Pre-Menopausal Women

May 30, 2014

Abrams, Tomaszewski To Co-Direct DCTD

June 10, 2011

Genetics Research Is Prevalent In Central Europe as Scientists Seek Answers To Related Questions

August 16, 1991

Phase III Trial Data: Lenvatinib Extends PFS by Over 14 Months

June 27, 2014

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

FDA says green tea unlikely to prevent cancer.

July 8, 2005